About Larson Pharma Private Limited
Data last updated: 08 February 2026
Larson Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 20 April 2006, the company has been in operation for over 20 years.
Registered with ROC Hyderabad under CIN U24239AP2006PLC049977.
Capital: an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.45 Cr. Formerly known as Larson Pharma Limited and Sasank Biotech Limited. It is led by directors Yeturu Sita Mahalakshmi and Yeturu Srinivasa Reddy.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No 187 Mig Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.93 Cr, a growth of 23% compared to the previous year.
The company has a workforce of approximately 28 employees as per the latest available data.
The company is associated with 1 brand - Larson Pharma. As per MCA filings, the company has open charges of ₹13.64 Cr and satisfied charges of ₹5.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website larsonpharma.in.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressPlot No 187 Mig Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049
-
IndustryPharma, API Manufacturers, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Larson Pharma Private Limited
Larson Pharma Private Limited has undergone 2 name changes throughout its history. The company was previously known as Larson Pharma Limited, and Sasank Biotech Limited. The current legal name is Larson Pharma Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Larson Pharma Private Limited | Current |
| Larson Pharma Limited | Previous |
| Sasank Biotech Limited | Previous |
CIN History of Larson Pharma Private Limited
Larson Pharma Private Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24233TG2006PTC049977, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2006PTC049977 | Current |
| U24239AP2006PLC049977 | Previous |
| U24233TG2006PLC049977 | Previous |
| U24239TG2006PLC049977 | Previous |
Associated Brands with Larson Pharma Private Limited
Larson Pharma Private Limited operates one associated brand: Larson Pharma. These brands represent Larson Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Specializes in manufacturing and supplying a range of pharmaceutical products and ingredients. | larsonpharma.in |
Competitors & Alternatives of Larson Pharma Private Limited
Brands and companies operating in the same space as Larson Pharma Private Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
|
|
APIs and intermediates are manufactured by Viyash as a CDMO. | Hyderabad, India, India | 2019 |
|
|
CDMO focused on manufacturing, supplier, and development of intermediates & APIs | Mumbai, India, India | 1969 |
|
|
Advanced API intermediates are manufactured for pharmaceutical use. | Surat, India, India | 2007 |
|
|
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | Hyderabad, India, India | 2008 |
|
|
APIs, intermediates, and finished dosage forms are manufactured. | Hangzhou, China, China | 2004 |
|
|
CDMO focused on manufacturing of APIs and intermediates | Berlin, Germany, Germany | 2019 |
|
|
Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. | Hyderabad, India, India | 2007 |
|
|
Manufactures and exports pharmaceutical intermediates for global markets. | Hyderabad, India, India | 2007 |
Business Activity of Larson Pharma Private Limited
Larson Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Larson Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Larson Pharma Private Limited
Larson Pharma Private Limited is currently managed by 2 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Yeturu Sita Mahalakshmi
Also directs:
Shivani Organics Private Limited, Ysr Pharma Private Limited
|
Director | 20 Dec 2011 | 14 Years 7 Months | Current |
| Yeturu Srinivasa Reddy | Director | 20 Apr 2006 | 20 Years 3 Months | Current |
Financials of Larson Pharma Private Limited FY 2025 filings available
Larson Pharma Private Limited reported revenue of ₹33.93 Cr (up 23.00% YoY) for FY 2025.
Ten-year financial statements for Larson Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Larson Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Others | ₹1.71 Cr | Open |
| 01 Jul 2022 | Hdfc Bank Limited | ₹14.57 Lakh | Open |
| 12 May 2022 | Axis Bank Limited | ₹11.65 Cr | Open |
| 18 Apr 2022 | Hdfc Bank Limited | ₹13.58 Lakh | Open |
| 16 Jul 2021 | Canara Bank | ₹1.95 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Larson Pharma Private Limited
View historical data on people associated with Larson Pharma Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Larson Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Larson Pharma Private Limited
GST registrations and filing compliance for Larson Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Larson Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Larson Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Larson Pharma Private Limited
MSME payment history for Larson Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Larson Pharma Private Limited
Corporate group structure for Larson Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Larson Pharma Private Limited
MCA filings and documents for Larson Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Larson Pharma Private Limited
Frequently Asked Questions about Larson Pharma Private Limited
Larson Pharma Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 20 April 2006 (20+ years old) and is registered under CIN U24233TG2006PTC049977. The company has 28 employees.
Larson Pharma Private Limited reported revenue of ₹33.93 Cr for FY 2025 (up 23.00% YoY).
The current directors of Larson Pharma Private Limited are:
- Yeturu Sita Mahalakshmi - Director
- Yeturu Srinivasa Reddy - Director
The primary industry of Larson Pharma Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Larson Pharma Private Limited can be reached at the registered office: Plot No 187 Mig Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049, or through the website larsonpharma.in.
The authorised capital is ₹6.5 Cr, and the paid-up capital is ₹6.45 Cr.